Search
forResearch 10 of 1000+
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
- LPA-producing enzyme PA-PLA<sub>1</sub>α regulates hair follicle development by modulating EGFR signalling
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →